Discovery & Development

Engineers from Rutgers used 4D printing to create tiny needles with backward-facing barbs. Could these replace hypodermic needles?

Electronic locking features and a child-resistant design cinched the “Best Innovation in Drug Delivery Device” award at Pharmapack 2020.

How can the progression of Parkinson's disease be slowed?

Repurposing drugs could accelerate the development of a new cystic fibrosis drug.

Why are compounds still failing at the final hurdle?

Sitting down with… Matthew Todd, Chair of Drug Discovery at UCL and founder of the Open Source Pharma movement.

Explore TOSOH’s expertise across all stages of therapeutic antibody development.

How is pharma using advances in technology to its benefit?

A cell-free biologic could act as platform therapeutic for a variety of serious diseases.

What needs to change to improve our odds in the fight against AMR?